Navigation Links
New Dermatological Formula Targets Psoriasis, Eczema and Other Extreme Skin Conditions
Date:9/13/2011

ORMOND BEACH, Fla., Sept. 13, 2011 /PRNewswire/ -- Florida-based SkinHealth Technology introduces a powerful, breakthrough formula that combines cutting-edge cosmeceutical ingredients -- peptides, polysaccharides and botanical emollients -- with a proven skin protectant to help combat even the most serious skin conditions. ExtremeSkinCare Intense Treatment Balm helps reduce the unsightly appearance of psoriasis, eczema, and rosacea and relieve inflamed and irritated skin without steroids.

Millions of Americans are affected by psoriasis, eczema, rosacea or other troublesome skin conditions, leaving them searching for a safe, effective topical treatment.

Dermatologist Jeffrey Parks, MD and a team of skincare experts have developed a formulation containing a perfect combination of ingredients that help reduce inflammation, redness and clear affected skin of plaques.

ExtremeSkinCare Intense Treatment Balm:

  • Helps reduce inflammation, redness, itching and irritation
  • Protects and relieves dry, cracked and scaling skin
  • Increases skin's resistance to further physical damage by 60%
  • Helps improve skin elasticity and stimulates collagen synthesis

SkinHealth Technology LLC, an R&D based development company which formulates advanced dermatological, therapeutic skincare products, was founded in 2008. Jeffrey Parks, MD and a team of skincare professionals develop effective formulas that address bruising, acne, vitamin D deficiency, sun damage and chronic skin conditions.

For more detailed information about ExtremeSkinCare Intense Treatment Balm or to schedule an interview, please contact Jack Surrette at 386.236.9949 or visit http://www.skinhealthtech.com.

Contact:

Jack Surrette
Executive Director
SkinHealth Technology LLC
P.O. Box 731626, Ormond Beach, FL 32173
386.236.9949 or jes@skinhealthtech.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE SkinHealth Technology LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nations Top Heart Hospitals
3. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
4. Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
5. Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space
6. Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure
7. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
8. Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations
9. Biosynthetic corneas formulated with recombinant collagen restore vision and nerve growth
10. Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use
11. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 2017  If only one in every hundred ... resistance to chemotherapy, thousands of cancer cells would ... on finding these mutations in ever-smaller subpopulations of ... DNA in blood — to guide treatment decisions ... Unfortunately, however, detecting these genetic anomalies may be ...
(Date:2/16/2017)... (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the power of ... negative breast cancer (TNBC), announced today their completion of the ... The YEi Start in France ... business in France and Europe.  ImMAGE ... an intensive one week immersion in France ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology:
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
(Date:1/19/2017)... Oregon and PUNE, India , January 19, 2017 ... Research, titled, "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," ... growing at a CAGR of 9.6% from 2016 to 2022. In 2015, ... owing to high-level security for both public and private sectors. ... ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
Breaking Biology News(10 mins):